Agile Therapeutics Stock News

Agile Therapeutics has finished its first full year as a commercial company and was able to establish an attractive growth curve for Twirla in several metrics.

Partners with Award-Winning Director Maya Albanese

AGRX earnings call for the period ending December 31, 2021.

Agile Therapeutics (AGRX) delivered earnings and revenue surprises of -17.65% and 3.87%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Twirla Demand Grows with Cycles Dispensed and Total Prescriptions (TRx) Up 35% and 33% Respectively in Fourth Quarter 2021 vs Third Quarter 2021

Agile Therapeutics, Inc.'s (AGRX) CEO Al Altomari on Q4 2021 Results - Earnings Call Transcript

Agile Therapeutics (AGRX) delivered earnings and revenue surprises of -17.65% and 3.87%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Agile Therapeutics (AGRX) is down ~6% pre-market after announcing a $4.85M equity offering.The women''s healthcare company entered into a securities purchase agreement with a…

In the last trading session, 1.51 million shares of the Agile Therapeutics Inc. (NASDAQ:AGRX) were traded, and its beta was 1.19. Most recently the company’s share price was $0.25, and it changed around $0.0 or 0.59% from the last close, which brings the market valuation of the company to $30.36M. AGRX currently trades at a … Agile Therapeutics Inc. (NASDAQ: AGRX) Could See Prices Soar In The Coming Months Read More »

The trading price of Agile Therapeutics Inc. (NASDAQ:AGRX) closed lower on Monday, March 07, closing at $0.25, -9.64% lower than its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << Traders who pay close attention to intraday price movement should know that it fluctuated between $0.25 … Making Sense Of Agile Therapeutics Inc.’s (NASDAQ:AGRX) Volatility Read More »

Live Conference Call and Webcast at 4:30 p.m. ET Live Conference Call and Webcast at 4:30 p.m. ET

Live Conference Call and Webcast at 4:30 p.m. ET Live Conference Call and Webcast at 4:30 p.m. ET

Agile Therapeutics Inc. (NASDAQ:AGRX) concluded the trading at $0.35 on Friday, February 04 with a rise of 3.24% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.34 and 5Y monthly beta was reading 0.99 with its price kept floating in the … Analysts Provide Insight On How High Agile Therapeutics Inc. (AGRX) Can Go Read More »

Agile Therapeutics Inc (AGRX) shares closed 3.0% lower than its previous 52 week low, giving the company a market cap of $48M. The stock is currently down 18.6% year-to-date, down 86.0% over the past 12 months, and down 84.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 77.6% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 3.9% lower than its 5-day moving average, 20.4% lower than its 20-day moving average, and 48.5% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1575.9% The company's stock price performance over the past 12 months lags the peer average by 1400.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Agile Therapeutics Inc (AGRX) shares closed today at 1.6% above its 52 week low of $0.39, giving the company a market cap of $48M. The stock is currently down 18.7% year-to-date, down 86.2% over the past 12 months, and down 84.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 0.6%. Trading Activity Trading volume this week was 6.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -6080.5% The company's stock price performance over the past 12 months lags the peer average by 1933.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.